Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000541271 | SCV000653666 | likely benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491094 | SCV002797243 | likely benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5; Thyrotoxic periodic paralysis, susceptibility to, 1 | 2022-04-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451200 | SCV004177891 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451201 | SCV004177893 | likely benign | Thyrotoxic periodic paralysis, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458459 | SCV004177894 | likely benign | Congenital myopathy 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451199 | SCV004177895 | likely benign | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003451200 | SCV004824179 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2023-12-01 | criteria provided, single submitter | clinical testing |